Related Experiment Video
Updated: Aug 23, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Combined antithrombotic therapy for acute coronary syndrome
Meinrad Gawaz1, Iris Müller, Felicitas Besta
1Deutsches Herzzentrum and 1. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich, Germany. gawaz@dhn.mhn.de
Insights
Combined antithrombotic therapy, including aspirin and newer agents like clopidogrel, offers improved treatment for acute coronary syndromes (ACS). This approach expands options for managing ACS and preventing future events.
Area of Science:
- Cardiology
- Pharmacology
- Internal Medicine
Background:
- Acute coronary syndromes (ACS) management has advanced with combined antithrombotic therapies.
- Aspirin, while standard, has limitations like intolerance and peptic ulceration.
- Newer agents like glycoprotein IIb/IIIa inhibitors and clopidogrel expand antiplatelet options.
Purpose of the Study:
- To summarize recent findings on combined antithrombotic therapy for ACS.
- To provide an understanding of the basis for current combined antithrombotic strategies.
- To review pathological and clinical knowledge relevant to ACS treatment.
Main Methods:
- Review of recent findings in antithrombotic therapy for ACS.
- Synthesis of existing pathological and clinical knowledge.
- Focus on combined antiplatelet and oral anticoagulation strategies.
Main Results:
- Combined antithrombotic therapy shows significant therapeutic advances in ACS.
- Expanded options for acute and chronic antiplatelet therapy are available.
- Combination of antiplatelet therapy and oral anticoagulation is effective for secondary prevention of ACS.
Conclusions:
- Combined antithrombotic therapy is a key advancement in ACS treatment.
- Newer agents and combinations offer improved patient management.
- Understanding the underlying pathology and clinical data supports current therapeutic approaches.
Abstract:
Remarkable therapeutic advances in the treatment of acute coronary syndromes (ACS) have been made with combined antithrombotic therapy. Aspirin is accepted as standard therapy in the management of ACS but has significant limitations, including intolerance, resistance, and peptic ulceration. With the intravenous platelet glycoprotein IIb/IIIa inhibitors and the new thienopyridine clopidogrel, the options for acute and chronic antiplatelet therapy have expanded. Recently, the combination of antiplatelet therapy and oral anticoagulation has gained much interest and has been shown to be effective in secondary prevention of ACS. This article summarizes important recent findings on the background of existing pathological and clinical knowledge to provide an understanding of the basis of current combined antithrombotic therapy.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
